Drug Shortage Report for AURO-LOSARTAN HCT
Report ID | 148907 |
Drug Identification Number | 02423642 |
Brand name | AURO-LOSARTAN HCT |
Common or Proper name | LOSARTAN HCT |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30's & 100's |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-11-05 |
Estimated end date | |
Actual end date | 2023-12-06 |
Shortage status | Resolved |
Updated date | 2023-12-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-12-07 | English | Compare |
v9 | 2023-12-06 | French | Compare |
v8 | 2023-12-06 | English | Compare |
v7 | 2022-09-28 | French | Compare |
v6 | 2022-09-28 | English | Compare |
v5 | 2022-08-15 | French | Compare |
v4 | 2022-08-15 | English | Compare |
v3 | 2021-11-06 | English | Compare |
v2 | 2021-11-05 | French | Compare |
v1 | 2021-11-05 | English | Compare |
Showing 1 to 10 of 10